| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |